Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway–dependent Rho/ROCK signaling
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2424904122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Asja Guzman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Columbia University, New York, NY 10027. Hauptthemen laut MEDLINE: Mevalonic Acid, Tumor Suppressor Protein p53, rho-Associated Kinases, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute (NCI).
Abstract (Originalsprache)
Certain TP53 mutations can confer neomorphic gain of function (GOF) activities to the p53 protein that affect cancer progression. Yet the concept of mutant p53 GOF has been challenged. Here, using various strategies to alter the status of mutant versions of p53 in different cell lines, we demonstrate that mutant p53 stimulates cancer cell invasion in three-dimensional environments. Mechanistically, mutant p53 enhances RhoA/ROCK-dependent cell contractility and cell-mediated extracellular matrix (ECM) reorganization via increasing mevalonate pathway–dependent RhoA localization to the membrane. In line with this, RhoA-dependent proinvasive activity is also mediated by IDI-1, a mevalonate pathway product. Further, the invasion-enhancing effect of mutant p53 is dictated by the biomechanical properties of the surrounding ECM, thereby adding a cell-independent layer of regulation to mutant p53 GOF activity that is mediated by dynamic reciprocal cell–ECM interactions. Together our findings link mutant p53 metabolic GOF activity with a context-dependent invasive cellular phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Columbia University, New York, NY 10027.
- Astellas Pharma Inc., Tsukuba-shi, Ibaraki 305-8585, Japan.
- Department of Chemistry, Columbia University, New York, NY 10027.
- Herbert Irving Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032.
- Department of Physics, Columbia University, New York, NY 10027.
ORCID-Profile: Tatsuya Kawase, Carol Prives
Förderung
- NCI NIH HHS
- HHS | NIH | National Cancer Institute (NCI)
Zitieren
APA
Guzman, A., Kawase, T., Devanny, A. J., Efe, G., Navaridas, R., Yu, K., Regunath, K., Mercer, I. G., Avard, R. C., Muniz de Queiroz, R., Rustgi, A. K., Kaufman, L. J., & Prives, C. (2025). Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway–dependent Rho/ROCK signaling. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2424904122
Vancouver
Guzman A, Kawase T, Devanny AJ, Efe G, Navaridas R, Yu K, et al. Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway–dependent Rho/ROCK signaling. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2424904122
BibTeX
@article{Guzman2025,
author = {Guzman, Asja and Kawase, Tatsuya and Devanny, Alexander J and Efe, Gizem and Navaridas, Raúl and Yu, Karen and Regunath, Kausik and Mercer, Iris G and Avard, Rachel C and Muniz de Queiroz, Rafaela and Rustgi, Anil K and Kaufman, Laura J and Prives, Carol},
title = {Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway–dependent Rho/ROCK signaling},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2424904122}
}
EUVIMED